Literature DB >> 21546494

Rapid diagnosis of chronic myeloid leukemia by flow cytometric detection of BCR-ABL1 protein.

Claire M Lucas, Jemma L Fagan, Anthony Carter, Bryony Swale, Craig Evans, Richard E Clark, Robert J Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21546494      PMCID： PMC3128231          DOI： 10.3324/haematol.2011.043166

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Conventional Western blotting techniques will not reliably quantify p210BCR-ABL1 levels in CML mononuclear cells.

Authors:  Hetal Patel; Stephen B Marley; Myrtle Y Gordon
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

2.  The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemia.

Authors:  Lihui Wang; Kevin Pearson; Julia E Ferguson; Richard E Clark
Journal:  Br J Haematol       Date:  2003-03       Impact factor: 6.998

3.  Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies.

Authors:  Maher Albitar; Kim-Anh Do; Marcella M Johnson; Francis J Giles; Iman Jilani; Susan O'Brien; Jorge Cortes; Deborah Thomas; Laura Z Rassenti; Thomas J Kipps; Hagop M Kantarjian; Michael Keating
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

4.  Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia.

Authors:  Anna Rogers; Youngson Joe; Taghi Manshouri; Amanda Dey; Iman Jilani; Francis Giles; Elihu Estey; Emil Freireich; Michael Keating; Hagop Kantarjian; Maher Albitar
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

5.  Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia.

Authors:  Lihui Wang; Kevin Pearson; Lynne Pillitteri; Julia E Ferguson; Richard E Clark
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

6.  An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation.

Authors:  Iman Jilani; Hagop Kantarjian; Homan Faraji; Mercedes Gorre; Jorge Cortes; Oliver Ottmann; Kapil Bhalla; Susan O'Brien; Francis Giles; Maher Albitar
Journal:  Leuk Res       Date:  2007-12-26       Impact factor: 3.156
  6 in total
  3 in total

1.  Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques.

Authors:  Anna Grazia Recchia; Nadia Caruso; Sabrina Bossio; Mariavaleria Pellicanò; Laura De Stefano; Stefania Franzese; Angela Palummo; Vincenzo Abbadessa; Eugenio Lucia; Massimo Gentile; Ernesto Vigna; Clementina Caracciolo; Antolino Agostino; Sara Galimberti; Luciano Levato; Fabio Stagno; Stefano Molica; Bruno Martino; Paolo Vigneri; Francesco Di Raimondo; Fortunato Morabito
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

2.  Evaluation of a new flow cytometry based method for detection of BCR-ABL1 fusion protein in chronic myeloid leukemia.

Authors:  Swati Dasgupta; Ujjal K Ray; Arpita Ghosh Mitra; Deboshree M Bhattacharyya; Ashis Mukhopadhyay; Priyabrata Das; Sudeshna Gangopadhyay; Sudip Roy; Soma Mukhopadhyay
Journal:  Blood Res       Date:  2017-06-22

3.  Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia.

Authors:  Donatella Raspadori; Paola Pacelli; Anna Sicuranza; Elisabetta Abruzzese; Alessandra Iurlo; Daniele Cattaneo; Antonella Gozzini; Sara Galimberti; Claudia Baratè; Patrizia Pregno; Maura Nicolosi; Federica Sorà; Mario Annunziata; Luigiana Luciano; Giovanni Caocci; Sabrina Moretti; Nicola Sgherza; Claudio Fozza; Sabina Russo; Emilio Usala; Marina A Liberati; Sara Ciofini; Monika M Trawinska; Alessandro Gozzetti; Monica Bocchia
Journal:  Cytometry B Clin Cytom       Date:  2019-02-03       Impact factor: 3.058
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.